Geode Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,144,217
Closed -$20.6M 4230
2020
Q2
$20.6M Buy
1,144,217
+44,807
+4% +$806K ﹤0.01% 1490
2020
Q1
$7.84M Buy
1,099,410
+77,143
+8% +$550K ﹤0.01% 1886
2019
Q4
$24.4M Buy
1,022,267
+77,159
+8% +$1.84M 0.01% 1431
2019
Q3
$25.3M Buy
945,108
+73,683
+8% +$1.98M 0.01% 1319
2019
Q2
$23.6M Buy
871,425
+65,666
+8% +$1.78M 0.01% 1367
2019
Q1
$28M Buy
805,759
+75,510
+10% +$2.62M 0.01% 1189
2018
Q4
$14.3M Buy
730,249
+33,734
+5% +$658K ﹤0.01% 1523
2018
Q3
$18.5M Buy
696,515
+30,605
+5% +$815K 0.01% 1466
2018
Q2
$25.2M Buy
665,910
+71,234
+12% +$2.69M 0.01% 1190
2018
Q1
$19.4M Sell
594,676
-26,237
-4% -$857K 0.01% 1286
2017
Q4
$30.2M Buy
620,913
+44,612
+8% +$2.17M 0.01% 973
2017
Q3
$31.1M Buy
576,301
+87,623
+18% +$4.73M 0.01% 933
2017
Q2
$27.4M Buy
488,678
+6,946
+1% +$390K 0.01% 978
2017
Q1
$18.9M Buy
481,732
+41,524
+9% +$1.63M 0.01% 1194
2016
Q4
$9.88M Buy
440,208
+27,207
+7% +$611K ﹤0.01% 1581
2016
Q3
$9.38M Sell
413,001
-59
-0% -$1.34K ﹤0.01% 1543
2016
Q2
$9.75M Buy
413,060
+14,181
+4% +$335K 0.01% 1446
2016
Q1
$8.14K Sell
398,879
-4,597
-1% -$94 ﹤0.01% 1534
2015
Q4
$20.8M Buy
403,476
+44,231
+12% +$2.28M 0.01% 871
2015
Q3
$15.3M Buy
359,245
+6,597
+2% +$281K 0.01% 1048
2015
Q2
$16.1M Buy
352,648
+11,256
+3% +$513K 0.01% 1079
2015
Q1
$13M Buy
341,392
+37,016
+12% +$1.41M 0.01% 1190
2014
Q4
$8.62M Buy
304,376
+38,611
+15% +$1.09M 0.01% 1448
2014
Q3
$6.72M Buy
265,765
+185,921
+233% +$4.7M ﹤0.01% 1571
2014
Q2
$2.33M Buy
79,844
+19,513
+32% +$569K ﹤0.01% 2281
2014
Q1
$1.56M Buy
60,331
+12,884
+27% +$334K ﹤0.01% 2495
2013
Q4
$1.22M Buy
47,447
+2,225
+5% +$57.3K ﹤0.01% 2590
2013
Q3
$1.21M Buy
45,222
+26,458
+141% +$708K ﹤0.01% 2491
2013
Q2
$461K Buy
+18,764
New +$461K ﹤0.01% 2919